Therefore, we aimed to investigate the prognostic role of loss of ARID1A (ARID1A−) in people with cancer regarding overall mortality, cancer-specific mortality, and recurrence of disease, hypothesizing that ARID1A− would be associated with a poorer prognosis compared to the presence of ARID1A (ARID1A+). This evidence concerns the gene ARID1A and cancer.